Description: Living benefits (GLWBs) in fixed index annuity products are typically accounted for under SOP03-1 under current GAAP guidance. LDTI requires companies to classify these riders as Market Risk Benefit (MRB). This webcast focuses on challenges and considerations of the MRB implementation. Industry practices of the reserving approach will be shared during this webcast, as well as hedging and pricing implications.

Description: 2021 Life Meeting - Session 8E: Insurance M&A Valuation Methodologies and Considerations 9.1.21 Recording

Description: 2021 Life Meeting - Session 1C: Earnings Pressure Impact on Annuity Product Development and the Insurance-Linked Securities Market

Description: Explore real-life experiences implementing LDTI for traditional life and annuity products. Learn about strategies that worked well and pitfalls to avoid in the future. Topics include data and assumption management, building disclosures for attribution analyses and roll-forwards, discount rates, implementing new DAC calculations, reinsurance accounting methods, and risk-neutral ESGs and processes to calculate Market Risk Benefits.

Description: The annuity market has been declining while the Registered Index Linked Annuity (RILA) market has been expanding. Discover why the market is growing along with key features and considerations for the product from an actuarial perspective.

Description: 2021 Life Meeting - Session 8F: Smaller Insurance Company Chief Actuary and Appointed Actuary Forum 9.1.21 Recording

Description: Join a discussion on the tax implications for direct writers ceding annuity blocks for both onshore and offshore reinsurance arrangements. Get an introduction to the tax consequences of the risk transfer of annuity features and guarantees to reinsurers to reinsurers that are U.S.-based and not U.S. domiciled.

Description: Gain a high-level understanding on how long-duration targeted improvement (LDTI) impacts insurance products and earnings. Explore highlights on secondary impacts to companies due to additional complexity of LDTI, such as a need for a source of earnings analysis. Then dive into the details and hear an explanation on how earnings emergence differs for each type of life and annuity product impacted by LDTI. Finally, discuss the impact -to-earnings volatility under LDTI for each product type. Close the session by connecting how the investor story changes with all the impacts discussed during the session.You should walk away with a good understanding of LDTI earnings emergence, which is a topic that has very limited thought leadership available today.

Description: This session will kick off the key National Association of Insurance Commissioners (NAIC) activities with a primary focus on updates to principle-based reserve valuations and appointed actuary topics. Hear insights into the current set of activities and initiatives being considered and/or adopted by the NAIC Life Actuarial Task Force (LATF) and the NAIC Risk Based Capital Working Group as well as Actuarial Standards Board. In addition, other actuarial practice issues and other appointed actuary and opinion topics relevant to life insurance, variable annuities and fixed annuities will be discussed. By the end of the session, attendees will understand what changes are being made to reserves, RBC, PBR and actuarial standards and related topics, and the anticipated timing of such emerging changes.

Description: Guarenteed Minimum Benefits of type x (GMxB) riders under ASU 2018-12, the Long Duration Targeted Improvements (LDTI) guidance, are now classified as Market Risk Benefits (MRBs). There are several acceptable approaches for calculating the MRB balance on a block of GMxBs. Depending on the product provisions, certain approaches may be more desirable than others. IThis session will give you the opportunity to examine different strategies for calculating the MRB liability for GMxB riders under LDTI.By the end of the session, you will understand the pros and cons of the several approaches permitted for calculating the MRB balance on a block of GMxBs.